Pharmacologic Treatment of Rett Syndrome With Glatiramer Acetate

Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2

Ruthie E. Amir, Ignatia B. Van den Veyver, Mimi Wan et al. · Nature Genetics · 1999 · 5K citations

Life Sciences, Genetics, Molecular Genetics +9

Rett syndrome: Revised diagnostic criteria and nomenclature

Jeffrey L. Neul, Walter E. Kaufmann, Daniel G. Glaze et al. · Annals of Neurology · 2010 · 1.4K citations · Full text

Life Sciences, Genetics, Neurology +17

Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice

Daniela Tropea, Emanuela Giacometti, Nathan R. Wilson et al. · Proceedings of the National Academy of Sciences · 2009 · 595 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

The Disease Progression of Mecp2 Mutant Mice Is Affected by the Level of BDNF Expression

Qiang Chang, Gargi Khare, Vardhan S. Dani et al. · Neuron · 2006 · 579 citations · Full text

Life Sciences, Neurobiology, Neuroscience +12

Characterisation of breathing and associated central autonomic dysfunction in the Rett disorder

Peter O.O. Julu, Alison Kerr, Flora Apartopoulos et al. · Archives of Disease in Childhood · 2001 · 280 citations · Full text

Medicine, Neurology, Neuroscience +16